![Jean-Claude Jelsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Claude Jelsch
Algemeen Directeur bij CellProthera SAS
Oorsprong van het eerstegraads netwerk van Jean-Claude Jelsch
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
CellProthera SAS
![]() CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France.
6
| Holding Company | Medical/Nursing Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Claude Jelsch via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IP2IPO Innovations Ltd.
![]() IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chief Executive Officer |
Statistieken
Internationaal
Frankrijk | 2 |
Verenigd Koninkrijk | 2 |
Nederland | 2 |
Sectoraal
Health Technology | 2 |
Commercial Services | 2 |
Health Services | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Founder | 1 |
President | 1 |
Sterkste connecties
- Beurs
- Insiders
- Jean-Claude Jelsch
- Bedrijfsconnecties